Clinical Trial Update: Intra-arterial Magnesium Administration for Acute Stroke [Phase 1, Phase 2]

View source ↗

Summary

This update reports the termination of a Phase 1/2 trial evaluating intra-arterial magnesium sulfate for acute stroke, with results posted on August 28, 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: University of Southern California | Conditions: Acute Stroke | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-08-28